Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ZIVOW - Zivo Bioscience Inc


Previous close
0   0%

Share volume: 0
Last Updated:
Biological Product (except Diagnostic) Manufacturing : -4.32%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
76%
Profitability 93%
Dept financing 25%
Liquidity 0%
Performance 90%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
145.83%
6 Months
233.33%
1 Year
170.64%
2 Year
0.31%
Key data
Stock price
N/A
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.15 - $0.99
52 WEEK CHANGE
$170.64
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
804.043 K
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Andrew Dahl
Region: US
Website: https://zivobioscience.com/
Employees: 0
IPO year: -
Issue type:
Market: XNAS
Industry: Biological Product (except Diagnostic) Manufacturing
Sector: Manufacturing

zivo bioscience, inc., a u.s.-based r&d firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.

Recent news